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SUMMARY. CONCLI]DING REMARKS. AND FUTURE PERSPECTIVES
Renal cell cancers (RCCs) are epithelial neoplasms that demonstrate a diversity of
morphologic characteristics and clinical manifestations. Presently used classifications as
from the V/HO include gross, histological, and ultrastructural features, resulting in a
classification of adenomas, renal cell carcinoma, and other tumors, without further
subclassification. Based on such classifications, no conclusions can be drawn on oncoge-
nesis, tumorprogression and biological behavior (and subsequently differences in clinical
behavior) of these tumors.
In 1986 a more extended and refined cytomorphologically def,rned subtyping of renal cell
tumors, based on new electron microscopical and histochemical observations, was pro-
posed by Thoenes and Stórkel (1986). Based on the analysis of more than 1200 epithelial
renal tumors, a relationship was suggested between cells of the different parts of the
tubulus as cell of origin for different subtypes of renal cell carcinoma (Chapter 1).
Chapter 2 deals with the cytogenetic as well as molecular genetic aspects of renal
epithelial tumors. Cell suspensions from a large series of renal cell tumors were
successfully cultured, ild parts of tissue were fresh frozen (-80'C), parts embedded in
paraffin for routine histology. Good qualitity karyotypes were obtained from about 90Vo
of the cultures. The cytogenetic and molecular genetic studies indicate that certain specific
chromosomal abnormalities correlate with different histological subtypes of renal tumors
and their clinical behaviour, ild may be important for the diagnosis and prognosis of
these conditions. The clear cell and the chromophilic type are characterized by different
specific chromosomal abnormalities: loss of heterozygosity on 3p is only found in the
clear cell compact type and trisomy 17 tn the (chromophilic) tubulo-papillary type. It
appears that some of the chromosomal abnormalities occur alone or in specific combina-
tions and show a correlation with tumor type or tumor grade. In the different subtypes of
renal cell tumors, according to the classification as proposed by Thoenes et al. we found
the chromosomal abnormalities shown in Chapter 2.1 and Figure 1. The most important
are structural aberrations of chromosomes I,3,4,5q,6, 10q, 1lq, and 12q together with
polysomy of chromosomes X, 4, 5, 7, 70, 12, 15, 16, 19,20,21, and 22, and monoso-
my of chromosomes 3, 8, 9, 13, 14, and loss of Y in the clear cell type. The main
characteristics of the chromophilic type are trisomies 7 and 17, and loss of the Y-chromo-
some. Chromophobic carcinoma seems to be correlated with, among others, polysomy 7,
trisomies 12, 16, 18, 19, structural abnormalities of 1lq, and telomeric associations.
Oncocytomas show trisomy 7. A subgroup of this tumors is charactenzed by t(5;11)
(q35;q13) (Chapter 3.1). Trisomy 17 seems to be associated with tubulo-papillary growth
pattern, because it was also observed in "mixed" tumors with clear cells and a tubulo-
papillary growth pattern (unpublished observation). Monosomy 8, 9 and 14 seem to be
correlated with a higher grade in clear cell tumors, as are polysomies 12, 16 and 20 rn
chromophilic tumors. Also structural aberrations (and probably loss of heterozygosity) of
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Abnormalities involving chromosomes I,16, 17, and 2lhave also been found in other
epithelial malignant lesions like carcinoma of the bladder, colorectum, breast and pan-
creas. In colorectal carcinoma chromosomes 1,7,8, 13, 17, and 18 seem frequently
involved. Molecular genetic studies havepinpointed critical genes, e.g. mcc on 5q21, p53
on chromosome 17, and dcc on chromosome 18, as important for tumorigenesis [1,2].
Whereas cytogenetic investigations are open-framed (all chromosome aberrations are
revealed), molecular genetic analyses are highly specific (only those aberrations are
revealed that one tests for) [3]. Heterogeneity and clonal evolution can be assessed by
cytogenetics, but can cause a problem in molecular genetics [3]. We developed a new and
objective method to visualize the relationships between different karyotypes from the
same tumor in one patient through mapping cytogenetic changes on minimal spanning
trees. Analysis of differences between karyotypes by using a minimum spanning tree as a
presumed path of tumor evolution has two advantages: non-clonal abnormalities can be
included in the analysis and differences found can be subjected to an objective form of
frequency analysis.
Karyotyping on purely morphological grounds necessarily implies a significant risk of
misinterpretation. The same is true for an analysis based solely on allelic losses by
Southern blotting. Microscopic and molecular genetic techniques have to cornplement
each other. Therefore, we analyzed loss of heterozygosity of chromosome 3 in matched
renal cell tumor/normal kidney tissue pairs. Using the classification as proposed by
Thoenes and Stórkel (1986), allelic losses were restricted to the clear cell category,
indicating that either only clear cell tumors arise as a consequence of loss of a
tumorsuppressor gene on 3p, or in non-clear cell tumors the loss is more subtle and
therefore undetectable, as yet (Chapter 2.2).
To get more insight in the role of certain frequent chromosomal abnormalities (loss of the
Y-chromosome and trisomy 7 ín particular) in oncogenesis, a large series of normal renal
tissue from patients with RCC was studied (Chapter 2.3). These findings indicate that
these aberrations might be involved in the process of (malignant) degeneration. Whether
clones with trisomy 7 represent a subgroup of immunologic cells that participate in local
immune reaction [in a] or represent supposed epithelial-mesenchymal transition cells in
culture as suggested by Herrmann et al. [4] remains to be elucidated.
Chapter 3 describes the discovery of a second subgroup of oncocytomas, apart from the
one with -Y,-1, charactenzeÀ by t(5;11Xq35;q13) (Chapter 3.1). In chapter 3.2 a clear
cell tumor with oncocytic-like areas is described with the same breakpoint 11q13 as in
one of the subgroups of the oncocytomas, possibly indicating a relationship between the
two entities.
Chapter 4 deals with the finding of an i(12p) in a testicular metastasis of a RCC. An
i(12p) is thought to be virtually specific for germ cell tumors where it is found in over
80% of cases. However, the possibility of a germ cell tumor was ruled out, which left us
with two explanations: either this finding (as a secondary change) might be merely
coincidental, or the host environment in the gonads favours tumor cells with an i(12p).
Adhesion molecules are known to play an important role in the biological behavior of
tumors, including tumor cell invasion and metastasis. The study described in Chapter 5
focussed on the expression of the molecules involved in cell-cell and cell-matrix
interactions. In addition, we tried to determine whether different parts of the renal tubule
had a specific micro-environment, as reflected by specific micro-environmental
extracellular matrix protein composition in the different tumor subtypes. An attempt was
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made to relate tumor-associated presence or absence of antigen expression to cytogenetic
findings to see if tumorgenetic changes cause disturbances function and/or antigen expres-
sion. No relationship could be shown. Our results show differential expression of the B1
integrins, depending on histological subtype. No clear relationship with particular
oncogenic changes of different parts of the tubular system was found. However, the
number of cases is too limited and too unevenly distributed over the different subtypes to
draw firm conclusions yet. It turned out that a distinction could be made between clear
cell carcinoma and chromophilic carcinoma by differences in membrane expression of the
vitronectin receptor (CD51) and VLAcyl (CDw49a) and by the presence of vitronectin
in/on tumor cells. Oncocytomas were negative for VLA-o5 while the tumors from the
proximal tubule were positive.
In chapter 6 cytogenetic results from two very rare, non-epithelial renal tumors are
described: a carcinoid derived from neuro-ectodermal cells arising in the isthmus of a
horseshoe kidney (Chapter 6.1) and a leiomyosarcoma of the kidney (Chapter 6.2).
CONSEQUENCES FOR ONCOGENESTS OF RENAL CELL TIIMORS
Different subtypes of renal cell carcinoma might originate from cells of the different parts
of the renal tubulus. Taken together, cytogenetic and molecular genetic studies of recent
years have demonstrated that certain specific chromosomal abnormalities correlate with
different histological subtypes of renal tumors. Chromosomal abnormalities are believed
to be responsible for neoplastic transformation, tumor growth and tumor progression [5].
Cancergenetic studies might reveal the cell of origin, oncogenetic steps and relationship of
tumors.
To date there are no really distinct criteria to reliably distinguish renal adenomas from
carcinomas. About 99% of renal adenomas are chromophilic, no clear cell adenomas can
be found. About 14% of the renal carcinomas are chromophilic and 75% are of the clear
cell type, 3Vo of the renal carcinomas are mixed tumors of the clear cell and chromophilic
type (other forms of mixture of basic tumor cell types have never been found).
So one might ask whether there is no relationship between renal cell adenomas and
carcinomas, or whether there is progression from adenomas to chromophilic carcinomas
to clear cell carcinomas. The chromosomal pattern of the different types of tumors,
especially of the different parts of mixed tumors might reveal this relationship and pro-
gression model. A similar study was done in the adenoma-carcinoma sequence in
colorectal neoplasia and revealed a series of consecutive genetic alterations involved [1].
The view of a relation between renal cell adenomas and carcinomas is strengthened by the
fact that oncocytomas and adenomas occasionally show a malignant behavior. A
reasonable explanation for this exceptional behavior is that oncocytomas and adenontas
probably represent the benign side of a spectrum of renal cell tumors, with renal cell
carcinoma at the other extreme. If the "spectrum" concept for adenomas and carcinomas
is correct, then it may be expected that there would also exist an overlap in some of the
characteristics of these benign and malignant tumors. Referring to this concept, the
chromophobic carcinoma could be the malignant counterpart of the oncocytoma. Both
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